Physician profile
Dawn Panasy
NPI 1982835823
$3,162.85
in general payments reported to CMS, 2019-2025
20 companies · $22.46 in 2025
The $22.46 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $702 · 2023: $1,524 · 2024: $914 · 2025: $22.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,460.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,010.97 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $897.65 | 2022-2024 | Breztri, Farxiga, Airsupra |
| Amgen INC. | $195.08 | 2022-2024 | Repatha, Otezla |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $186.20 | 2022-2024 | Xifaxan |
| Exact Sciences Corporation | $172.26 | 2023-2024 | Cologuard Collection Kit |
| Csl Behring | $147.10 | 2022-2024 | Hizentra |
| Novo Nordisk INC | $118.45 | 2023-2024 | Rybelsus, Ozempic, Wegovy |
| Abbott Laboratories | $60.47 | 2023 | Freestyle Libre 3, Freestyle Libre 2 |
| Novartis Pharmaceuticals Corporation | $60.40 | 2022-2023 | |
| Lilly USA, LLC | $59.44 | 2022-2023 | Jardiance, Emgality |
| Bayer Healthcare Pharmaceuticals INC. | $49.02 | 2023 | |
| Pfizer INC. | $41.02 | 2024 | |
| Upsher-Smith Laboratories LLC | $35.17 | 2022-2023 | |
| Glaxosmithkline, LLC. | $22.46 | 2025 | Nucala |
| Phathom Pharmaceuticals, INC. | $22.14 | 2024 | Voquezna |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $19.63 | 2023 | Inpen Smart Insulin Delivery System |
| Biohaven Pharmaceutical Holding Company LTD. | $19.12 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $16.87 | 2023 | Acanya |
| Takeda Pharmaceuticals U.S.A., INC. | $16.05 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.35 | 2023 | Synjardy, Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawn Panasy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.